Vector | CMC | Analytics Services

We offer full-service AAV vector production capabilities that support our partners’ needs.

Scalable AAV Vector Production for Every Stage of Development

AAV vector production plays a critical role in the development of genetic medicines, supporting everything from early discovery and preclinical research to clinical trial readiness. Reliable, scalable manufacturing is essential to advancing safe and effective therapies.

Engage Our Scientists and Industry Leaders

Franklin Biolabs is a trusted partner for academic and industry researchers developing virus-based vectors for gene transfer in preclinical and translational research. With over 27,000 research batches produced for clients in more than 30 countries, our team brings deep experience and global reach to every project. Our capsid technology has supported more than 50 clinical-stage programs, and we have completed over 50 GMP manufacturing runs—all contributing to a 100% IND approval success rate since 2019. Vector manufacturing at Franklin Biolabs is powered by a robust platform of analytical assays designed to support a wide range of genetic medicine products.

Established adherent and suspension platforms with on-site GLP capabilities

150,000 sq. ft. of manufacturing, analytics, and in vivo study areas

Supported >3,000 investigators

Research Vector Production

Manufacturing AAV vectors is a critical early step in developing genetic medicines. This complex process includes plasmid design and optimization, scalable production, and detailed product analysis. Research-grade vectors are essential for a wide range of preclinical in vitro and in vivo studies.

Research Vector Production Services:

Consultation
DNA Services

Production
Analytics

Research Vector Orders

Place your research-grade AAV vector order today and accelerate your preclinical studies with reliable, high-quality production you can trust.

Order Here

Process Development

AAV-based gene therapy manufacturing faces numerous challenges that may arise from a limited understanding of AAV biology or the lack of established analytical tools and production processes.

Our deep expertise and unique insights into product-specific behavior enable process development that supports robust and effective platform technologies. With cutting-edge process technologies such as high-density suspension or adherent-based culture and novel analytics available, we can accelerate the development of your advanced therapy program from discovery through commercialization.

Large-Scale Manufacturing

Scaling up vector production is a vital step in the development of genetic medicines. Building on initial research-scale efforts, end-to-end large-scale manufacturing and analytics ensure sufficient high quality material is available to support more extensive preclinical studies and generate the critical data needed to meet global regulatory requirements. This phase is essential for progressing promising therapies toward clinical evaluation.

Analytics

Analytical testing is essential to the development of genetic medicines, providing critical insight into product quality, safety, and biological activity from preclinical through clinical stages. Advanced technologies support regulatory compliance and ensure high standards are maintained throughout development.